跳至主要内容
临床试验/NCT02308215
NCT02308215已完成不适用

Retinal Therapy Guided by 3D OCT Image Analysis

Michael Abramoff1 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2010年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
77
试验地点
1
主要终点
Measure central retinal layer thickness in µms.

研究概览

简要总结

The main purpose is to find a better way to predict the timing of treatments given to patients with Wet Age-related macular degeneration using image analysis.

详细描述

The study focuses on making better use of advanced three-dimensional imaging and analysis to allow physicians to know when a treatment is being effective and thus not overuse it. The study will examine how 3-D optical coherence tomography and related image analysis can be used to assess changes in the macula and retina of patients' eyes. These changes can reveal how well a person is responding to anti-VEGF treatment and thus help doctors provide proper treatment timing and care.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
45 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • fundoscopically confirmed AMD and patient eligible for treatment with anti-VEGF

排除标准

  • Patients with a CNV due to other causes (OHS, trauma)
  • eyes that have been previously treated for CNV

结局指标

主要结局

Measure central retinal layer thickness in µms.

时间窗: one year

Measure amount of fluid in the retina in µms.

时间窗: one year

次要结局

未报告次要终点

研究者

发起方
Michael Abramoff
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Michael Abramoff

Professor

University of Iowa

研究点 (1)

Loading locations...

相似试验